VBIV Annual Total Liabilities
$79.42 M
-$11.50 M-12.65%
31 December 2023
Summary:
As of January 29, 2025, VBIV annual total liabilities is $79.42 million, with the most recent change of -$11.50 million (-12.65%) on December 31, 2023. During the last 3 years, it has risen by +$41.76 million (+110.86%).VBIV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly Total Liabilities
$80.91 M
+$1.49 M+1.87%
31 March 2024
Summary:
As of January 29, 2025, VBIV quarterly total liabilities is $80.91 million, with the most recent change of +$1.49 million (+1.87%) on March 31, 2024. Over the past year, it has increased by +$1.33 million (+1.67%).VBIV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.7% | +1.7% |
| 3 y3 years | +110.9% | -11.0% |
| 5 y5 years | +101.2% | -11.0% |
VBIV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -12.6% | -11.0% |
VBI Vaccines Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $80.91 M(+1.9%) |
| Dec 2023 | $79.42 M(-12.6%) | $79.42 M(-1.8%) |
| Sept 2023 | - | $80.90 M(+1.7%) |
| June 2023 | - | $79.58 M(-4.6%) |
| Mar 2023 | - | $83.44 M(-8.2%) |
| Dec 2022 | $90.92 M(+36.9%) | $90.92 M(+3.1%) |
| Sept 2022 | - | $88.19 M(+32.4%) |
| June 2022 | - | $66.60 M(+3.4%) |
| Mar 2022 | - | $64.44 M(-2.9%) |
| Dec 2021 | $66.39 M(+76.3%) | $66.39 M(+3.6%) |
| Sept 2021 | - | $64.08 M(+13.3%) |
| June 2021 | - | $56.55 M(+31.9%) |
| Mar 2021 | - | $42.89 M(+13.9%) |
| Dec 2020 | $37.67 M(+11.0%) | $37.67 M(+11.6%) |
| Sept 2020 | - | $33.75 M(-2.4%) |
| June 2020 | - | $34.57 M(+5.4%) |
| Mar 2020 | - | $32.80 M(-3.4%) |
| Dec 2019 | $33.95 M(-14.0%) | $33.95 M(-2.2%) |
| Sept 2019 | - | $34.72 M(-9.6%) |
| June 2019 | - | $38.40 M(-2.9%) |
| Mar 2019 | - | $39.55 M(+0.2%) |
| Dec 2018 | $39.47 M(+52.6%) | $39.47 M(+24.5%) |
| Sept 2018 | - | $31.70 M(+6.0%) |
| June 2018 | - | $29.89 M(+5.4%) |
| Mar 2018 | - | $28.36 M(+9.6%) |
| Dec 2017 | $25.87 M(+23.1%) | $25.87 M(+1.4%) |
| Sept 2017 | - | $25.51 M(+12.7%) |
| June 2017 | - | $22.63 M(+7.1%) |
| Mar 2017 | - | $21.13 M(+0.5%) |
| Dec 2016 | $21.02 M(+333.4%) | $21.02 M(+111.2%) |
| Sept 2016 | - | $9.96 M(+8.4%) |
| June 2016 | - | $9.18 M(+78.3%) |
| Mar 2016 | - | $5.15 M(+6.1%) |
| Dec 2015 | $4.85 M(+1654.4%) | $4.85 M(+6.1%) |
| Sept 2015 | - | $4.57 M(+396.5%) |
| June 2015 | - | $921.00 K(+233.1%) |
| Mar 2015 | - | $276.50 K(+25.2%) |
| Mar 2015 | $276.50 K(+11.1%) | - |
| Dec 2014 | - | $220.90 K(+30.6%) |
| Sept 2014 | - | $169.20 K(-25.5%) |
| June 2014 | - | $227.10 K(-8.7%) |
| Mar 2014 | $248.80 K(+3.7%) | $248.80 K(+55.2%) |
| Dec 2013 | - | $160.30 K(+14.8%) |
| Sept 2013 | - | $139.60 K(-1.4%) |
| June 2013 | - | $141.60 K(-41.0%) |
| Mar 2013 | $240.00 K(-66.2%) | $240.00 K(-23.7%) |
| Dec 2012 | - | $314.70 K(+8.1%) |
| Sept 2012 | - | $291.10 K(-6.2%) |
| June 2012 | - | $310.20 K(-56.3%) |
| Mar 2012 | $710.00 K | $710.00 K(+47.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $482.80 K(-54.4%) |
| Sept 2011 | - | $1.06 M(+57.9%) |
| June 2011 | - | $670.70 K(-98.6%) |
| Mar 2011 | $49.53 M(>+9900.0%) | $49.53 M(+1390.7%) |
| Dec 2010 | - | $3.32 M(+48.8%) |
| Sept 2010 | - | $2.23 M(+924.4%) |
| June 2010 | - | $218.00 K(+6.5%) |
| Mar 2010 | $204.70 K(+27.3%) | $204.70 K(-7.4%) |
| Dec 2009 | - | $221.00 K(+53.8%) |
| Sept 2009 | - | $143.70 K(-33.3%) |
| June 2009 | - | $215.40 K(+34.0%) |
| Mar 2009 | $160.80 K(-17.0%) | $160.80 K(+30.1%) |
| Dec 2008 | - | $123.60 K(-1.5%) |
| Sept 2008 | - | $125.50 K(-27.9%) |
| June 2008 | - | $174.00 K(-10.2%) |
| Mar 2008 | $193.70 K(+36.7%) | $193.70 K(-13.6%) |
| Dec 2007 | - | $224.20 K(-1.0%) |
| Sept 2007 | - | $226.40 K(+37.7%) |
| June 2007 | - | $164.40 K(+16.0%) |
| Mar 2007 | $141.70 K(-42.2%) | $141.70 K(-59.1%) |
| Dec 2006 | - | $346.30 K(+46.6%) |
| Sept 2006 | - | $236.20 K(-13.9%) |
| June 2006 | - | $274.20 K(+11.8%) |
| Mar 2006 | $245.30 K(-0.2%) | $245.30 K(-25.5%) |
| Dec 2005 | - | $329.30 K(+10.3%) |
| Sept 2005 | - | $298.50 K(+12.7%) |
| June 2005 | - | $264.80 K(+7.7%) |
| Mar 2005 | $245.90 K(+38.4%) | $245.90 K(+8.5%) |
| Dec 2004 | - | $226.70 K(+2.8%) |
| Sept 2004 | - | $220.50 K(+26.7%) |
| June 2004 | - | $174.00 K(-2.1%) |
| Mar 2004 | $177.70 K(-8.7%) | $177.70 K(-15.3%) |
| Dec 2003 | - | $209.70 K(+6.7%) |
| Sept 2003 | - | $196.50 K(-3.8%) |
| June 2003 | - | $204.20 K(+4.9%) |
| Mar 2003 | $194.70 K(+46.2%) | $194.70 K(+8.8%) |
| Dec 2002 | - | $178.90 K(+9.3%) |
| Sept 2002 | - | $163.70 K(+8.9%) |
| June 2002 | - | $150.30 K(+12.8%) |
| Mar 2002 | $133.20 K(+188.9%) | $133.20 K(+44.5%) |
| Dec 2001 | - | $92.20 K(+15.4%) |
| Sept 2001 | - | $79.90 K(+37.0%) |
| June 2001 | - | $58.30 K(+26.5%) |
| Mar 2001 | $46.10 K(-80.5%) | $46.10 K(+12.7%) |
| Dec 2000 | - | $40.90 K(-4.9%) |
| Sept 2000 | - | $43.00 K(-81.8%) |
| Mar 2000 | $236.70 K(+78.6%) | $236.70 K(+78.6%) |
| Mar 1999 | $132.50 K(+88.2%) | $132.50 K(+88.2%) |
| Mar 1998 | $70.40 K(>+9900.0%) | $70.40 K(+0.7%) |
| Dec 1997 | - | $69.90 K |
| Mar 1997 | $0.00 | - |
FAQ
- What is VBI Vaccines annual total liabilities?
- What is the all time high annual total liabilities for VBI Vaccines?
- What is VBI Vaccines annual total liabilities year-on-year change?
- What is VBI Vaccines quarterly total liabilities?
- What is the all time high quarterly total liabilities for VBI Vaccines?
- What is VBI Vaccines quarterly total liabilities year-on-year change?
What is VBI Vaccines annual total liabilities?
The current annual total liabilities of VBIV is $79.42 M
What is the all time high annual total liabilities for VBI Vaccines?
VBI Vaccines all-time high annual total liabilities is $90.92 M
What is VBI Vaccines annual total liabilities year-on-year change?
Over the past year, VBIV annual total liabilities has changed by -$11.50 M (-12.65%)
What is VBI Vaccines quarterly total liabilities?
The current quarterly total liabilities of VBIV is $80.91 M
What is the all time high quarterly total liabilities for VBI Vaccines?
VBI Vaccines all-time high quarterly total liabilities is $90.92 M
What is VBI Vaccines quarterly total liabilities year-on-year change?
Over the past year, VBIV quarterly total liabilities has changed by +$1.33 M (+1.67%)